[{"Assets_0_Q2_USD":25511800000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":166700000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":160600000.0,"EarningsPerShareBasic_2_Q2_USD":17.65,"EarningsPerShareBasic_1_Q2_USD":9.6,"StockholdersEquityConverted_0_Q2_USD":11289200000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":167000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":160900000.0,"StockholdersEquity_0_Q2_USD":11308700000.0,"RevenuesConverted_2_Q2_USD":7215900000.0,"RevenuesConverted_1_Q2_USD":3681600000.0,"NetIncomeLossConverted_2_Q2_USD":2941200000.0,"NetIncomeLossConverted_1_Q2_USD":1542100000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":3415800000.0,"EarningsPerShareDiluted_1_Q2_USD":9.59,"EarningsPerShareDiluted_2_Q2_USD":17.61,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200722"}]